School of Medicine


Showing 21-40 of 131 Results

  • Katie Cederberg

    Katie Cederberg

    Postdoctoral Scholar, Psychiatry

    BioDr. Cederberg's primary research interests focus on studying the efficacy and effectiveness of exercise for managing symptoms of restless legs syndrome (RLS) and co-occurring conditions (e.g., periodic limb movements, insomnia). She is currently an NHLBI T32 funded Postdoctoral Scholar in the Mignot Lab, where she she devotes her time to conducting research aimed at better understanding the relationship among genetics, proteomics, and the presence of and severity of symptoms related to RLS. Her current research is interested in patient's personal experiences with exercise and RLS as well as the relationship between exercise and proteomic biomarkers of RLS. She received her PhD in Rehabilitation Science from the University of Alabama at Birmingham in December 2020, wherein her dissertation utilized a series of methodological approaches to comprehensively examine the relationship between physical activity and RLS in adults with MS. She plans to utilize her experience and training to develop a line of research for informing exercise prescription parameters specifically for managing symptoms of RLS.

  • Lacey Chetcuti

    Lacey Chetcuti

    Postdoctoral Scholar, Psychiatry

    BioDr. Chetcuti, Ph.D., is a postdoctoral academic researcher within Stanford University’s Autism and Developmental Disorders Research Program (https://med.stanford.edu/autism.html) within the Department of Psychiatry and Behavioral Sciences. She earned her doctoral degree from La Trobe University in Australia, specializing in developmental psychopathology and psychometrics. Dr. Chetcuti's research primarily focuses on advancing the measurement and characterization of individual differences in social-affective functioning in individuals with autism and other psychiatric conditions. Her work takes a lifespan perspective, acknowledging the dynamic nature of behavior across different life stages and its interaction with the environment. Dr. Chetcuti has actively collaborated with leading researchers in the United States, Europe, and Australia, contributing to the development of early developmental interventions to enhance functional social-affective outcomes while also analyzing individual difference factors that predict variable response to such approaches. Dr. Chetcuti possesses expertise in advanced statistical modeling techniques and is a core member of the newly-established Program for Psychometrics and Measurement-Based Care (https://med.stanford.edu/sppmc.html), dedicated to bridging the gap between the science of measurement development and clinical practice.

  • Bruna de Freitas Dias

    Bruna de Freitas Dias

    Postdoctoral Scholar, Psychiatry

    BioI am a Brazilian physician and neuroscientist with a special interest in autoimmune neurological diseases. I graduated from Albert Einstein Medical School, Sao Paulo – Brazil in 2021. My research predominantly focuses on studying the epidemiology of autoimmune encephalitis and genetic susceptibility to the disease onset. Furthermore, I am interested in assessing the burden of the disease in those patients, socioeconomic analysis, and environmental and infectious triggers for the disease onset. At Mignot’s Lab, I am involved in IGNITE project, and I am working in the association of clinical and epidemiological data, KIR sequencing, and GWAS analysis.

    My interests include general neurology, neuroimmunology, neuroscience, healthcare, and technology.

  • Chunyang Dong

    Chunyang Dong

    Postdoctoral Scholar, Psychiatry

    BioChunyang Dong completed his Ph.D. studies from University of California, Davis with Dr. Lin Tian, where he specialized in protein engineering to develop genetically encoded biosensors to enable real-time imaging of neuromodulator dynamics. As part of his postdoctoral pursuits with Dr. Sergiu Pasca at Stanford University, he hopes to combine disciplines between biosensors and modeling human neurological disease using brain region-specific organoids. Despite this shift, his unwavering goal is to deepen the understanding of brain development, disease processes, and translate research to potential treatments for neurological disorders.

  • Igor D. Bandeira

    Igor D. Bandeira

    Postdoctoral Scholar, Psychiatry

    BioIgor D. Bandeira, M.D., Ph.D., is a physician-scientist from Salvador in Brazil, working as a Postdoctoral Research Fellow in the Department of Psychiatry and Behavioral Sciences at Stanford University. He completed his Doctor of Medicine (M.D.) at the Federal University of Bahia (Brazil), where he received the prestigious Professor Alfredo Thomé de Britto Award for outstanding graduate scientific research. Part of his medical training took place at the University of Sydney (Australia) through a Science Without Borders Scholarship. In parallel with his formal graduate training, he worked as a researcher at the university’s Brain and Mind Centre during this period. As an attending physician, Dr. Bandeira acquired further clinical experience at the Brazilian Ministry of Health. Furthermore, during the pandemic, Dr. Bandeira worked on the Brazilian frontline in the fight against Covid-19. With respect to research, he has several years’ experience applying noninvasive brain stimulation techniques in the fields of neurology and psychiatry. During his Ph.D. at the Federal University of Bahia, Dr. Bandeira has also acquired expertise in developing clinical trials to test the efficacy of rapid-acting antidepressants. His work involved using ketamine and its enantiomers (e.g., esketamine and arketamine) for treatment-resistant depression (TRD) and bipolar depression. Since he arrived at Stanford, he has built on his previous training in clinical trials by leading (A) the Wellcome LEAP multisite accelerated intermittent theta burst stimulation (Stanford Neuromodulation Therapy) trial for anhedonic depression and co-leading (B) a trial testing the efficacy and safety of buprenorphine in sustaining the anti-suicide properties of ketamine.

  • Tianwei Du

    Tianwei Du

    Postdoctoral Scholar, Psychiatry

    BioDr. Du's clinical interests focus on providing evidence-based treatment to individuals with emotion dysregulation, interpersonal difficulties, and/or complex trauma. She is also passionate about addressing diversity factors in clinical work. Dr. Du provides services in the Dialectical Behavior Therapy (DBT) Adult Program, the Anxiety and Depression Adult Psychological Treatment (ADAPT) Clinic, and the Stanford Mental Health for Asians Research and Treatment (SMHART) Clinic. Dr. Du is a bilingual clinician speaking English and Mandarin.

    Dr. Du's research focuses on exploring the roles of interpersonal processes and personality in psychopathology, and she has published widely on this topic. Dr. Du also participated in a variety of clinical trials to help develop and improve evidence-based interventions for individuals with complex clinical presentations and populations with limited access to mental health care.

  • Cassondra Eng

    Cassondra Eng

    Postdoctoral Scholar, Psychiatry

    BioDr. Eng is a NIH funded T32 Sports Neuroscience Postdoctoral Scholar in the Center for Interdisciplinary Brain Sciences Research. She investigates optimizing immersive interventions that promote neurological, cognitive, and physical health outcomes from a multimethodological approach. Dr. Eng's research program focuses on attentional processes in varying technologically-enhanced contexts, with a focus on the neurophysiological mechanisms that produce differential outcomes using portable functional near-infrared spectroscopy (fNIRS), a modern neuroimaging technique ideal for children and neurodiverse populations because it is noninvasive and permits mobility in naturalistic settings. She specializes in utilizing behavioral, neurophysiological, and statistical methods across development: standard task-based and clinical norm-referenced assessments of attention, quantitative and qualitative assessments of children’s behavior and learning in ecological contexts; eye tracking, fNIRS, EEG, cardiovascular changes related to performance and stress; mixed effects modeling, multivariate analysis, educational data mining, and modern longitudinal data analysis.

    Dr. Eng earned her Ph.D. from Carnegie Mellon University in Developmental Psychology and Cognitive Neuroscience and Program for Interdisciplinary Education Research Certification through an Institute of Education Sciences-funded Predoctoral Fellowship after completing an NIH funded Post-Baccalaureate Research Education Program at Virginia Tech. She advocates for educational neuroscience: the field bridging cognitive science, psychology, educational technology, human-computer interaction, computer science and related disciplines to understand the optimal learning contexts that support brain development and cognitive skills crucial for overall wellbeing and success.

  • Afik Faerman

    Afik Faerman

    Postdoctoral Scholar, Psychiatry

    BioAfik Faerman, Ph.D., is a clinical neuropsychology postdoctoral scholar and an NIMH T32 fellow at the Stanford Brain Stimulation Lab (PI: Nolan Williams) and the Center for Mind, Body, and Health (PI: David Spiegel). He completed his clinical training at the University of California, San Francisco (UCSF) and Baylor College of Medicine and earned his Ph.D. in clinical psychology with emphasis in neuropsychology from Palo Alto University. His research centers on the modulation of consciousness and its clinical relevance, focusing on psychedelics, brain stimulation, hypnosis, sleep, and performance. His work has been acknowledged and supported by the American Psychological Association (APA), the Society for Clinical and Experimental Hypnosis (SCEH), the American Society for Clinical Hypnosis (ASCH), the Sleep Research Society (SRS), and more. He is the president-elect of the APA Division 30 (Psychological Hypnosis) and is the past chair of the Student Committee at the Association for the Scientific Study of Consciousness (ASSC).

  • Emily Ferguson, PhD

    Emily Ferguson, PhD

    Postdoctoral Scholar, Psychiatry

    BioEmily Ferguson, Ph.D., is a postdoctoral academic researcher and clinician within Stanford University’s Autism and Developmental Disorders Research Program (https://med.stanford.edu/autism.html) within the Department of Psychiatry and Behavioral Sciences. She earned her doctoral degree in Clinical Psychology from the University of California Santa Barbara and completed her clinical internship at the University of California Los Angeles. Dr. Ferguson's research focuses on advancing understanding of mechanisms of challenging behaviors in autistic youth and adults to inform treatment development. Her work takes a comprehensive perspective, integrating methods from implementation science to improve the accessibility and quality of clinical care for underserved autistic populations, especially those with higher support needs (or "profound autism"). She is also interested in developing methods to improve self-regulation in individuals with profound autism to effectively manage self-injurious behaviors and aggression. Dr. Ferguson is currently supporting research in the Preschool Autism Lab (https://med.stanford.edu/autismcenter/pre-school-autism-lab-program.html), and exploring profiles of challenging behaviors with the Program for Psychometrics and Measurement-Based Care (https://med.stanford.edu/sppmc.html) in a diverse range of autistic and non-autistic youth to inform treatment approaches.